Psychometric Properties of the Persian Version of Cystic Fibrosis Questionnaire: Revised in Children with Cystic Fibrosis

Naser Havaei, Mohammad Reza Modaresi, Mandana Rezaei, Mohammad Asghari‑Jafarabadi, Ameneh Kohzadi, Yalda Ariafar, Babak Ghalibaf, Sakineh Goljaryan


Background: Cystic fibrosis is a progressive, fatal disease affecting the quality of life. The cystic fibrosis questionnaire‑revised (CFQ‑R) is an efficient tool to monitor health‑related quality of life in patients. The aim of this study was to explore the psychometric properties of the child and parent versions of the Persian version of the CFQ‑R in the Iranian population. Methods: Fifty children with cystic fibrosis (6–11 years) and their parents were allocated in this methodological study to examine convergent validity, discriminant validity, test‑retest reliability (n = 30), internal consistency, ceiling and floor effects, and agreement between two versions of the CFQ‑R. Results: Convergent validity was confirmed for parent proxy (P < 0.05). CFQ‑R discriminated patients among stages of disease severity based on lung function, age, and BMI (P < 0.05). Test‑retest analysis revealed good to excellent reliability (inter‑class correlation coefficient (ICC) = 0.78–0.97). In most domains, lower quality of life scores was obtained in the parent proxy compared to the child version (P < 0.05). Domain‑specific correlations were found between the child version and parent proxy (P < 0.05). Internal consistency was generally confirmed (α = 0.13–0.83 in child version and α = 0.25–0.87 in parent proxy). There were no floor effects. Ceiling effects were mostly seen for physical, digestion, and body image domains in the child version and for eating, weight, and school domains in the parent proxy. Conclusions: The child version and parent proxy of the Persian CFQ‑R are valid and reliable measures and can be applied in clinical trials to monitor the quality of life in children with cystic fibrosis. It is recommended to use both versions in conjunction to better interpret the quality of life aspects of children with cystic fibrosis.


Cystic fibrosis; reliability; validity


Beaudet AL, Feldman GL, Fernbach SD, Buffone GJ,

O’Brien WE. Linkage disequilibrium, cystic fibrosis, and genetic

counseling. Am J Hum Genet 1989;44:319‑26.

Slack J, Houlston RS, Marteau T. Identification of the cystic

fibrosis gene. BMJ 1990;300:812.

Borgo G, Mastella G, Gasparini P, Zorzanello A, Doro R,

Pignatti P. Pancreatic function and gene deletion F508 in cystic

fibrosis. J Med genet 1990;27:665‑9.

Quittner AL. Measurement of quality of life in cystic fibrosis.

Curr Opin Pulm Med 1998;4:326‑31.

Schalock RL, Bonham GS, Verdugo MA. The conceptualization

and measurement of quality of life: Implications for program

planning and evaluation in the field of intellectual disabilities.

Eval Program Plann 2008;31:181‑90.

Rahimi A, Ahmadi F, Gholyaf M. Effects of applying continuous

care model on quality of life in hemodialysis patients. RJMS


Henry B, Aussage P, Grosskopf C, Goehrs JM. Development of

the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of

life in pediatric and adult patients. Qual Life Res 2003;12:63‑76.

Monti F, Lupi F, Gobbi F, Agostini F, Miano A, Gee L, et al.

Validation of the Italian version of the cystic fibrosis quality of

life questionnaire (CFQoL), a disease specific measure for adults

and adolescents with cystic fibrosis. J Cyst Fibros 2008;7:116‑22.

Goldbeck L, Schmitz TG. Comparison of three generic

questionnaires measuring quality of life in adolescents and adults

with cystic fibrosis: The 36‑item short form health survey, the

quality of life profile for chronic diseases, and the questions on

life satisfaction. Qual Life Res 2001;10:23‑36.

Quittner AL, Modi A, Cruz I. Systematic review of health‑related

quality of life measures for children with respiratory conditions.

Paediatr Respir Rev 2008;9:220‑32.

Quittner AL, Buu A, Messer MA, Modi AC, Watrous M.

Development and validation of the cystic fibrosis questionnaire

in the United States: A health‑related quality‑of‑life measure for

cystic fibrosis. Chest 2005;128:2347‑54.

Schmidt A, Wenninger K, Niemann N, Wahn U, Staab D.

Health‑related quality of life in children with cystic fibrosis:

Validation of the German CFQ‑R. Health Qual Life Outcomes


Klijn PH, van Stel HF, Quittner AL, van der Net J, Doeleman W,

van der Schans CP, et al. Validation of the Dutch cystic fibrosis

questionnaire (CFQ) in adolescents and adults. J Cyst Fibros


Yuksel H, Yilmaz O, Dogru D, Karadag B, Unal F, Quittner AL.

Reliability and validity of the cystic fibrosis questionnaire‑revised

for children and parents in Turkey: Cross‑sectional study. Qual

Life Res 2013;22:409‑14.

Yohannes AM, Dodd M, Morris J, Webb K. Reliability and

validity of a single item measure of quality of life scale for

adult patients with cystic fibrosis. Health Qual Life Outcomes


Wang WL, Lee HL, Fetzer SJ. Challenges and strategies of

instrument translation. West J Nurs Res 2006;28:310‑21.

Quittner AL, Sawicki GS, McMullen A, Rasouliyan L, Pasta DJ,

Yegin A, et al. Psychometric evaluation of the cystic fibrosis

questionnaire‑revised in a national sample. Qual Life Res


Gheissari A, Farajzadegan Z, Heidary M, Salehi F, Masaeli A,

Mazrooei A, et al. Validation of Persian version of PedsQLTM

0TM generic core scales in toddlers and children. Int J Prev

Med 2012;3:341‑50.

Taussig LM. Advances in cystic fibrosis: Bringing the bench to

the bedside. Eur J Pediatr 1995;154:S9‑10.

Modi AC, Quittner AL. Validation of a disease‑specific measure

of health‑related quality of life for children with cystic fibrosis.

J Pediatr Psychol 2003;28:535‑46.

Almanasreh E, Moles R, Chen TF. Evaluation of methods

used for estimating content validity. Res Social Adm Pharm


Porteny LG, Watkins MP. Foundations of Clinical Research:

Applications to Practice. Michigan: Mcgraw‑Hill/appleton &

Lange; 2009.

Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS.

Generic and specific measurement of health‑related quality of life

in a clinical trial of respiratory rehabilitation. J Clin Epidemiol


Koo TK, Li MY. A guideline of selecting and reporting intraclass

correlation coefficients for reliability research. J Chiropr Med


Upton P, Lawford J, Eiser CH. Parent–child agreement across

child health‑related quality of life instruments: A review of the

literature. Qual Life Res 2008;17:895‑913.

Landis JR, Koch GG. The measurement of observer agreement

for categorical data. Biometrics 1977;33:159‑74.

Fleiss J. The Design and Analysis of Clinical Experiments.

New York: Wiley; 1986.

Chronbach LJ. Cofficient alpha and the internal structure of tests.

Psychometrika 1951;16:297‑334.

Hochwalder J, Brucefors AB, Hjelte L. Psychometric evaluation

of the Swedish translation of the revised Cystic Fibrosis

Questionnaire in adults. Ups J Med Sci 2017;122:61‑6.

Quittner AL, Buu A. Effects of tobramycin solution for inhalation

on global ratings of quality of life in patients with cystic fibrosis

and Pseudomonas aeruginosa infection. Pediatr Pulmonol


Brengnballeh V, Thastum M, Lund LD, Lund CHR, Preissler T,

Schiøtz PF. Validation of the Danish version of the revised

cystic fibrosis quality of life questionnaire in adolescents and adults (CFQ‑R14+). J Cyst Fibros 2008;7:531‑6.

Rozov T, Cunha MT, Nascimento O, Quittner AL, Jardim JR.

Linguistic validation of cystic fibrosis quality of life

questionnaires. J Pediatr 2006;82:151‑6.

Havermans T, Vreys M, Proesmans M, De Boeck C. Assessment

of agreement between parents and children on health‑related

quality of life in children with cystic fibrosis. Child Care Health

Dev 2006;32:1‑7.